Antibiotic resistant bacteria threaten global health. Nevertheless, few new antibiotics have come onto the market in the last 50 years.
RP-12146 by Rhizen Pharmaceuticals for Endometrial Cancer: Likelihood of Approval
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes